XPH ETF (State Street SPDR S&P Pharmaceuticals ETF) is managed by State Street Investment Management with $313.4M in net assets. XPH expense ratio is 0.35%, holding 61 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-06-19.

XPH performance shows a YTD return of 3.91%. The 1-year return is 30.06% and the 5-year return is 2.79%. XPH dividend yield stands at 0.81%, paid quarterly.

XPH top holdings include Axsome Therapeutics, Inc (2.2%), Merck & Company Inc (2.1%), Mind Medicine Mindmed Inc (2.1%), Nuvation Bio Inc Pipe (2.1%), Zoetis Inc, Class A (2.1%). View all XPH holdings, sector breakdown, or dividend history.

XPH can be compared against other funds using the overlap calculator or side-by-side comparison tool. XPH alternatives are available via the screener, along with tax-loss harvesting opportunities.